Transplant related outcomes in patients with hematopoietic stem cell transplant with Clostridium difficile associated diarrhea

Leukemia and Lymphoma

Volumn 56, Issue 1, 2015, Pages 260-262

  Neemann, Kari ^a   Minhas, Veenu ^a   Loberiza, Fausto R ^a   Freifield, Alison ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; COMPLICATION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NEOPLASMS; OUTCOME ASSESSMENT; PEPTOCLOSTRIDIUM DIFFICILE;

CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; PATIENT OUTCOME ASSESSMENT;

EID: 84922349947     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.917637     Document Type: Letter

References (17)

1. Hensgens MP, Goorhuis A, Dekkers OM, et al. All-cause and disease-specif c mortality in hospitalized patients with Clostridium dif cile infection: a multicenter cohort study. Clin Infect Dis 2013;56:1108-1116.
2. Wenisch JM, Schmid D, Tucek G, et al. A prospective cohort study on hospital mortality due to Clostridium difcile infection. Infection 2012;40:479-484.
3. Anand A, Glatt AE. Clostridium dif cile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993; 17: 109-113.
4. van Kraaij MG, Dekker AW, Verdonck LF, et al. Infectious gastroenteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant 2000;26:299-303.
5. Arango JI, Restrepo A, Schneider DL, et al. IncidenceofClostridium dif cile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 2006;37:517-521.
6. Dubberke ER, Reske KA, Srivastava A, et al. Clostridium dif cile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant 2010;24:192-198.
7. Chopra T, Chandrasekar P, Salimnia H, et al. Recent epidemiology of Clostridium dif cile infection during hematopoietic stem cell transplantation. Clin Transplant 2011;25:E82-E87.
8. Willems L, Porcher R, Lafaurie M, et al. Clostridium dif cile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2012;18:1295-1301.
9. Alonso CD, Marr KA. Clostridium dif cile infection among hematopoietic stem cell transplant recipients: beyond colitis. Curr Opin Infect Dis 2013;26:326-331.
10. Triflio SM, Pi J, Mehta J. Changing epidemiology of Clostridium dif cile-associated disease during stem cell transplantation. Biol Blood Marrow Transplant 2013;19:405-409.
11. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium dif cile infection and colonization. N Engl J Med 2011;365:1693-1703.
12. Alonso CD, Treadway SB, Hanna DB, et al. Epidemiology and outcomes of Clostridium dif cile infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2012; 54: 1053-1063.
13. Debast SB, Bauer MP, Kuijper EJ et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): update of the treatment guidance document for Clostridium dif cile infection (CDI). Clin Microbiol Infect 2014;20(Suppl. 2):1-26.
14. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium dif cile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
15. Snell H, Ramos M, Longo S, et al Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 2004;42:4863-4865.
16. Quinn CD, Sefers SE, Babiker W, et al. C. Dif Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium dif cile in stool specimens. J Clin Microbiol 2010;48:603-605.
17. Wince JL, Elagin S, Kozak K, et al. Illumigene C. dif cile: a novel new molecular approach for the detection of Clostridium dif cile. Presented at the 110th General Meeting of the American Society for Microbiology, 23-27 May 2010, San Diego, CA: Poster Board Number 204.